Cover Image

Asunaprevir, a protease inhibitor for the treatment of hepatitis C infection

Ivan Gentile,1 Antonio Riccardo Buonomo,1 Emanuela Zappulo,1 Giuseppina Minei,1 Filomena Morisco,2 Francesco Borrelli,1 Nicola Coppola,3 Guglielmo Borgia1 1Section of Infectious Diseases, 2Section of Gastroenterology, Department of Clinical Medicine and Surgery, University of Naples Federico II, 3Se...

Full description

Saved in:

Bibliographic Details
Main Authors:	Gentile I (Author), Buonomo AR (Author), Zappulo E (Author), Minei G (Author), Morisco F (Author), Borrelli F (Author), Coppola N (Author), Borgia G (Author)
Format:	Book
Published:	Dove Medical Press, 2014-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Vertical transmission of hepatitis B virus: challenges and solutions
by: Gentile I, et al.
Published: (2014)

Effectiveness and safety of protease inhibitors for the hepatitis C treatment in a hospital of South Brazil: real life data
by: Aline Bianca Borba Mattana, et al.
Published: (2020)

The Ubiquitin-Specific Protease 18 Promotes Hepatitis C Virus Production by Increasing Viral Infectivity
by: Yujia Li, et al.
Published: (2019)

PRACTICE OF USING VIRAL PROTEASE INHIBITORS IN CHILDREN WITH HIV INFECTION
by: V.B. Denisenko, et al.
Published: (2010)

PRACTICE OF USING VIRAL PROTEASE INHIBITORS IN CHILDREN WITH HIV INFECTION
by: V.B. Denisenko, et al.
Published: (2010)

Cure of hookworm infection with a cysteine protease inhibitor.
by: Jon J Vermeire, et al.
Published: (2012)

Fasciola hepatica serine protease inhibitor family (serpins): Purposely crafted for regulating host proteases.
by: Carolina De Marco Verissimo, et al.
Published: (2020)

Effect of non-nucleoside reverse transcriptase inhibitors and protease inhibitors on serum levels of myeloperoxidase and C-reactive protein in HIV-infected individuals
by: Danielle Cristyane Kalva Borato, et al.
Published: (2022)

Simeprevir for the treatment of hepatitis C virus infection
by: Izquierdo L, et al.
Published: (2014)

Neurocognitive function among HIV-infected children on protease inhibitor -based versus non-protease inhibitor based antiretroviral therapy in Uganda: a pilot study
by: Damalie Nalwanga, et al.
Published: (2021)

Epidemiology and management of hepatitis C virus infections in immigrant populations
by: Nicola Coppola, et al.
Published: (2019)

Kinetic and thermodynamic characterisation of HIV-protease inhibitors against E35D↑G↑S mutant in the South African HIV-1 subtype C protease
by: Sibusiso Maseko, et al.
Published: (2019)

Process of Incorporation and Guidance in Public Health Systems for Protease Inhibitors in Chronic Hepatitis C in: a comparative case study between Brazil, Australia, Canada and England.
by: Fernanda Dias da SILVA, et al.
Published: (2015)

Process of Incorporation and Guidance in Public Health Systems for Protease Inhibitors in Chronic Hepatitis C in: a comparative case study between Brazil, Australia, Canada and England.
by: Fernanda Dias da SILVA, et al.
Published: (2015)

Interaction of hepatitis C virus with the immune system in pregnant women with chronic hepatitis C
by: A. P. Tsibulkin, et al.
Published: (2019)

Pharmacoinformatics approach for investigation of alternative potential hepatitis C virus nonstructural protein 5B inhibitors
by: Mirza MU, et al.
Published: (2015)

Changes in Blood Viscosity With Synthetic Protease Inhibitors
by: Masahito Hitosugi, et al.
Published: (2003)

Repurposing existing drugs: identification of SARS-CoV-2 3C-like protease inhibitors
by: Wei-Chung Chiou, et al.
Published: (2021)

CLINICAL AND PARACLINICAL FEATURES OF HEPATITIS B AND C FLOW IN EARLY-AGED CHILDREN WITH PERINATAL INFECTION
by: O.G. Shadrin, et al.
Published: (2019)

IrSPI, a tick serine protease inhibitor involved in tick feeding and Bartonella henselae infection.
by: Xiang Ye Liu, et al.
Published: (2014)

Elucidating the function of mycorrhizal-induced Kunitz protease inhibitors and characterization of their putative target proteases in Medicago truncatula
by: Hirsch, Stefanie S.
Published: (2014)

P6 Phylogenetic clustering of recent hepatitis C virus infection between 2004 and 2015
by: S.R. Bartlett, et al.
Published: (2017)

Psoriasis and porphyria cutanea tarda, associated with chronic hepatitis C in HIV-infected patients (clinical observation)
by: I. A. Korotaeva, et al.
Published: (2017)

The Use of Protease Inhibitors in Pregnancy: Maternal and Fetal Considerations
by: Elaine Duryea, et al.
Published: (2015)

Secretory Leukocyte Protease Inhibitor in Preterm Labor and Pregnancy
by: Ferriyanto Sutiono, et al.
Published: (2018)

Investigation of plant flavonoids as potential dengue protease inhibitors
by: Mangala K Jayadevappa, et al.
Published: (2020)

Plant Products as Inhibitors of Coronavirus 3CL Protease
by: Anirban Mandal, et al.
Published: (2021)

In silico investigation of HCV and RNA synthesis inhibitor antibiotic drugs as potential inhibitors of SARS‑CoV‑2 main protease (Mpro)
by: Merusomayajula V. Kishore, et al.
Published: (2024)

The prevalence of hepatitis C infection among the dentists of Yazd and assessment of their knowledge about hepatitis
by: Behnaz MA, et al.
Published: (2004)

Plant Protease Inhibitors as Emerging Antimicrobial Peptide Agents: A Comprehensive Review
by: Mónica G. Parisi, et al.
Published: (2024)

Hepatitis C virus infection characteristics and treatment outcomes in Canadian immigrants
by: Curtis L. Cooper, et al.
Published: (2020)

Secretory leukocyte protease inhibitor and its role in virus induced head and neck cancers
by: Ajila Vidya, et al.
Published: (2019)

Boceprevir and personalized medicine in hepatitis C virus infection
by: Habersetzer F, et al.
Published: (2012)

Occult Hepatitis B Virus infection in a cohort of patients with chronic Hepatitis C
by: MI Naga, et al.
Published: (2019)

Papain-Like Proteases as Coronaviral Drug Targets: Current Inhibitors, Opportunities, and Limitations
by: Anastasiia I. Petushkova, et al.
Published: (2020)

INVESTIGATION OF THE SIGNIFICANCE OF DETECTION OF THE NUCLEOCAPSID ANTIGEN OF THE HEPATITIS C VIRUS IN CHILDREN WITH CHRONIC HEPATITIS C
by: E. A. Leybman, et al.
Published: (2017)

Cost-effectiveness of Oral Protease Inhibitors Co-administration versus Pegylated Interferon-Α2b and Ribavirin Only for the Patients with Hepatitis C Genotype 1 in Kazakhstan Health Care Settings
by: Alima ALMADIYEVA, et al.
Published: (2018)

Oral candidiasis in HIV+ patients under treatment with protease inhibitors
by: Andréa Lusvarghi Witzel, et al.
Published: (2008)

Role of salivary leukocyte protease inhibitor in periodontal disease progression
by: Pateel Deepak, et al.
Published: (2010)

Protease inhibitor concentrations in the saliva of individuals experiencing oral dryness
by: Kenkichi Yamamoto, et al.
Published: (2021)